Baird Financial Group Inc. Has $373,000 Position in Bausch Health Companies Inc. (NYSE:BHC)

Baird Financial Group Inc. reduced its holdings in Bausch Health Companies Inc. (NYSE:BHCGet Rating) by 55.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,560 shares of the company’s stock after selling 54,602 shares during the period. Baird Financial Group Inc.’s holdings in Bausch Health Companies were worth $373,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Fountainhead AM LLC lifted its position in shares of Bausch Health Companies by 25.0% in the second quarter. Fountainhead AM LLC now owns 262,501 shares of the company’s stock worth $2,195,000 after purchasing an additional 52,417 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in Bausch Health Companies in the 2nd quarter worth approximately $410,000. Employees Retirement System of Texas boosted its stake in shares of Bausch Health Companies by 100.0% during the 2nd quarter. Employees Retirement System of Texas now owns 138,000 shares of the company’s stock valued at $1,154,000 after buying an additional 69,000 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. grew its holdings in shares of Bausch Health Companies by 10.5% during the 2nd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 103,609 shares of the company’s stock valued at $849,000 after acquiring an additional 9,810 shares in the last quarter. Finally, Segantii Capital Management Ltd increased its stake in shares of Bausch Health Companies by 281.3% in the second quarter. Segantii Capital Management Ltd now owns 5,700,000 shares of the company’s stock worth $47,652,000 after acquiring an additional 4,205,000 shares during the last quarter. 70.07% of the stock is currently owned by institutional investors and hedge funds.

Bausch Health Companies Trading Down 8.3 %

NYSE:BHC opened at $6.94 on Tuesday. The company’s 50 day moving average is $7.02 and its 200-day moving average is $7.60. The company has a quick ratio of 0.77, a current ratio of 1.05 and a debt-to-equity ratio of 48.05. Bausch Health Companies Inc. has a 12 month low of $4.00 and a 12 month high of $28.35. The firm has a market cap of $2.51 billion, a price-to-earnings ratio of 9.91, a P/E/G ratio of 0.13 and a beta of 0.99.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Royal Bank of Canada lifted their price objective on Bausch Health Companies from $4.50 to $8.00 and gave the company a “sector perform” rating in a research report on Thursday, September 1st. Truist Financial downgraded Bausch Health Companies from a “buy” rating to a “hold” rating in a report on Thursday, July 28th. JPMorgan Chase & Co. cut shares of Bausch Health Companies from an “overweight” rating to a “neutral” rating in a research note on Thursday, July 28th. StockNews.com started coverage on shares of Bausch Health Companies in a report on Wednesday, October 12th. They set a “hold” rating on the stock. Finally, Piper Sandler reduced their price objective on shares of Bausch Health Companies from $7.00 to $6.00 and set a “neutral” rating for the company in a research note on Friday, September 9th. Five research analysts have rated the stock with a hold rating, According to MarketBeat, Bausch Health Companies presently has an average rating of “Hold” and a consensus price target of $10.60.

About Bausch Health Companies

(Get Rating)

Bausch Health Companies Inc, together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.

Further Reading

Want to see what other hedge funds are holding BHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bausch Health Companies Inc. (NYSE:BHCGet Rating).

Institutional Ownership by Quarter for Bausch Health Companies (NYSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.